Virgin Galactic Holdings, Inc. - 10-Q Summary (Q3 2025)
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2025. Virgin Galactic is an aerospace and space travel company focused on developing, manufacturing, and operating spaceships for private individuals, researchers, and government agencies. The company is currently transitioning from its initial fleet to the development of next-generation Delta Class spaceships and launch vehicles.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | Q3 2024 (3 Months) | YTD 2025 (9 Months) | YTD 2024 (9 Months) |
|---|---|---|---|---|
| Revenue | $0.37 million | $0.40 million | $1.23 million | $6.61 million |
| Net Loss | $(64.42) million | $(74.54) million | $(216.18) million | $(270.33) million |
| Operating Loss | $(66.17) million | $(81.73) million | $(224.56) million | $(294.68) million |
| Cash & Equivalents | $128.79 million (as of Sept 30, 2025) | |||
| Marketable Securities | ||||
| Total Liquidity | $393.58 million (Cash + Securities) | |||
| Convertible Debt (2027 Notes) | $421.84 million (Net Carrying Value) | |||
| Net Loss Per Share | $(1.09) | $(2.66) | $(4.61) | $(11.66) |
Material Changes vs. Prior Period
- Expense Reduction: Total operating expenses decreased significantly year-over-year. For the nine months ended Sept 30, 2025, expenses were $225.8 million compared to $301.3 million in 2024. This was driven by a $56.1 million decrease in R&D and a $15.2 million decrease in Spaceline operations, primarily due to reduced subcontractor costs and lower cash compensation.
- Revenue Decline: Revenue for the nine months ended Sept 30, 2025, dropped to $1.2 million from $6.6 million in the prior year. The 2024 period included revenue from commercial spaceflights, whereas 2025 revenue is primarily from access fees as commercial flights are paused for fleet transition.
- Capital Expenditures: Capital expenditures increased to $155.9 million for the nine months ended Sept 30, 2025, compared to $86.1 million in the prior year, reflecting heavy investment in the next-generation fleet.
- Share Count: Weighted-average shares outstanding increased significantly due to at-the-market (ATM) offerings, rising from 23.2 million (YTD 2024) to 46.9 million (YTD 2025).
Outlook, Risks, and Management Commentary
- Flight Schedule: Management expects the flight test program for the new Delta Class spaceships to commence in Q3 2026. The first commercial research flight is targeted for Q4 2026, with private astronaut flights expected to follow 6-8 weeks later.
- Backlog: As of September 30, 2025, the company holds reservations for approximately 675 future astronauts, representing roughly $189 million in expected future revenue. Sales are currently paused and are expected to resume in Q1 2026.
- Liquidity: The company believes its current capital is sufficient to sustain operations for at least the next 12 months. It continues to raise capital through its 2024 ATM program, generating $109.2 million in gross proceeds in the first nine months of 2025.
- Legal Settlement: A preliminary settlement was reached regarding the Lavin class action lawsuit. The company recorded a net settlement expense of $2.4 million for the nine months ended Sept 30, 2025. The gross settlement is $8.5 million, with approximately $6.1 million expected to be covered by insurance.
- Risks: Key risks include delays in the next-generation vehicle development, safety issues, the ability to convert backlog into revenue, and the need for additional financing if capital consumption accelerates.
Investor Verification Checklist
- Verify the timeline for the Delta Class flight test program (Q3 2026) and the first commercial flight (Q4 2026).
- Monitor the execution of the $8.5 million Lavin settlement and the actual insurance reimbursement received.
- Track the rate of capital consumption versus the $393.6 million liquidity position to assess runway beyond 12 months.
- Confirm the resumption of sales reservations in Q1 2026 and the conversion rate of the 675-person backlog.
- Review the impact of continued dilution from the ATM program on per-share value.